IRIS
CAGNETTA, ANTONIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.720
AS - Asia 281
SA - Sud America 42
NA - Nord America 39
AF - Africa 2
Totale 6.084
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.714
SG - Singapore 115
CN - Cina 84
VN - Vietnam 61
US - Stati Uniti d'America 30
BR - Brasile 21
AR - Argentina 13
HK - Hong Kong 6
BD - Bangladesh 4
ID - Indonesia 4
IN - India 3
MX - Messico 3
PY - Paraguay 3
CA - Canada 2
EC - Ecuador 2
ES - Italia 2
IQ - Iraq 2
VE - Venezuela 2
CL - Cile 1
DE - Germania 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GB - Regno Unito 1
HN - Honduras 1
LB - Libano 1
MA - Marocco 1
NI - Nicaragua 1
PL - Polonia 1
SE - Svezia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 6.084
Salva come PNG Salva come JPEG
Città #
Genova 3.163
Genoa 1.701
Rapallo 484
Vado Ligure 350
Singapore 44
Beijing 32
Ho Chi Minh City 23
Hanoi 18
Ashburn 15
Bordighera 8
Hong Kong 6
Tianjin 6
Biên Hòa 3
Los Angeles 3
Perugia 3
Bắc Ninh 2
Chennai 2
Da Nang 2
Lambaré 2
Milan 2
Nha Trang 2
Aracaju 1
Arima 1
Bady Bassitt 1
Barquisimeto 1
Basra 1
Belo Horizonte 1
Berisso 1
Blida 1
Bolesławiec 1
Botucatu 1
Buenos Aires 1
Casablanca 1
Chapada Gaúcha 1
Chicago 1
Ciudad del Este 1
Cuautitlán Izcalli 1
Cuenca 1
Denver 1
Dhaka 1
Formosa 1
Frankfurt am Main 1
Guayaquil 1
Haiphong 1
Hangzhou 1
Houston 1
Humaitá Municipality 1
Hurlingham 1
Hải Dương 1
Itu 1
Lorena 1
Ludhiana 1
Macapá 1
Managua 1
Maracaibo 1
Mendoza 1
Merlo 1
Mexico City 1
Milltown 1
Montreal 1
Nanjing 1
New York 1
Ninh Bình 1
Paraty 1
Phoenix 1
Phú Thọ 1
Phủ Lý 1
Pimenta Bueno 1
Pindamonhangaba 1
Poplar 1
Providence 1
Punta Alta 1
Querétaro 1
Quilmes 1
Ranchillos 1
Recife 1
Rio Branco 1
Rosario 1
San José de Tango 1
San Juan 1
Santa Bárbara 1
Santa Clara 1
Santa Sylvina 1
Santiago de los Caballeros 1
Santo André 1
Saquarema 1
Sidoarjo 1
Sidon 1
Stockholm 1
Sulaymaniyah 1
Surakarta 1
Sátiro Dias 1
São Paulo 1
Tashkent 1
Tegucigalpa 1
Thái Bình 1
Toronto 1
Ubá 1
Viamão 1
Villa Tulumba 1
Totale 5.950
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 229
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents 220
APO866 activity in hematologic malignancies: a preclinical in vitro study. 215
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair. 206
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment 204
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 187
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 176
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 174
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 173
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 172
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 169
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 164
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology. 157
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 156
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 154
Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics. 153
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 152
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach 146
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 145
Nicotinamide Phosphoribosyltransferase As A Target In Inflammation-Related Disorders. 141
Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies 139
New insights into biology of chronic myeloid leukemia: implications in therapy. 137
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 137
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 133
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 132
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: Molecular mechanisms and therapeutic implications 132
Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity. 129
New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. 128
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma 127
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 126
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 125
MiR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth 123
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 121
Intracellular NAD+ depletion induces autophagic-death in Multiple Myeloma cells 113
SIRT6 inhibition as a novel approach for treating Acute Myeloid Leukemia 111
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma 102
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 96
Synergistic Interaction Between P-glycoprotein Inhibitors and APO866 in Primary Leukemic Cells 96
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells 96
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status 95
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 93
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 66
Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma 56
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 42
Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma 38
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses 8
Totale 6.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.303
article - articoli 20.303
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021260 0 0 0 0 0 27 27 37 30 53 51 35
2021/2022548 21 26 37 69 24 44 30 109 28 47 29 84
2022/2023601 67 67 3 73 97 86 6 37 85 12 64 4
2023/2024391 13 53 14 50 41 80 22 38 10 5 28 37
2024/20251.047 38 64 29 74 96 99 107 230 33 46 106 125
2025/2026895 234 52 103 212 244 50 0 0 0 0 0 0
Totale 6.194